DNDDF yields 1941.75% · PFE yields 6.20%● Live data
📍 DNDDF pulled ahead of the other in Year 1
Combined, DNDDF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DNDDF + PFE for your $10,000?
Dundee Sustainable Technologies Inc. engages in the development and commercialization of technologies for the treatment of refractory materials in the mining industry in Canada and internationally. It focuses on the commercialization of CLEVR process, which extracts precious metals, as well as removes and stabilizes contaminants, such as arsenic, antimony, and cadmium; and GlassLock process, which stabilizes arsenic, forms scorodite, and produces an insoluble glass residue that meets environmental requirements. The company extracts precious and base metals from ores, concentrates, and tailings. It also provides technical services to customers in the mining industry to evaluate processing alternatives. The company was formerly known as Nichromet Extraction Inc. and changed its name to Dundee Sustainable Technologies Inc. in January 2014. The company was incorporated in 1997 and is headquartered in Montreal, Canada. Dundee Sustainable Technologies Inc. is a subsidiary of Dundee Corporation.
Full DNDDF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.